Trimetazidine
Trimetazidine is a cardiovascular medication used to manage chest pain associated with Stable Angina Pectoris. It is commonly marketed as (Vastarel MR). Our current catalog features 1 option for this heart-focused therapy, providing a modified-release tablet formulation developed to support long-term metabolic health for the heart muscle.
Key points
- A metabolic agent that shifts heart muscle from fatty-acid to glucose metabolism, cutting the oxygen the heart needs to produce energy.
- Used long-term for stable angina pectoris rather than for relief during an acute attack, reducing how often episodes occur.
- Movement-related symptoms can appear in those with existing neurological considerations, alongside more common digestive discomfort or dizziness.
What is Trimetazidine?
Trimetazidine is a metabolic agent that addresses energy deficits in heart muscle cells that are oxygen-deprived. Unlike medications that primarily alter heart rate or blood pressure, this compound focuses on maintaining energy production to keep cardiac muscle functioning effectively under stress. It is often used as a long-term management strategy for patients with chronic heart conditions.
What Trimetazidine is used for
This medication is used for Stable Angina Pectoris. By optimising how the heart handles energy, it reduces the frequency and severity of angina attacks. It falls under the Heart & Blood Pressure category of therapies.
How does Trimetazidine work?
Trimetazidine works by protecting cardiac cells against the effects of low oxygen. By shifting heart muscle metabolism from relying on fatty acids to glucose, the heart requires less oxygen to produce energy. This metabolic protection ensures that the heart continues to function correctly even when blood supply is restricted during episodes of angina.
Trimetazidine brands and forms
Vastarel MR is the primary brand available for this heart medication. It is produced as a modified-release tablet, which provides a consistent concentration of the active ingredient throughout the day. This delivery method is chosen to ensure that the medication is effective over a twenty-four-hour period with simplified daily dosing requirements.
Safety overview for Trimetazidine
What to check before using this medicine
Ensure you confirm with your individual product leaflet to check for any specific contraindications or active ingredient sensitivities. This medication is typically reserved for long-term management of angina rather than immediate relief during an acute attack.
Possible reactions and tolerability
Common reactions can include digestive discomfort or dizziness. Some users may experience movement-related physical symptoms, particularly if they have underlying neurological considerations. Monitoring your response when starting the therapy is a recommended practice.
Interactions and health factors
Your liver and kidney function status can influence how this medication is processed by your system. Informing your healthcare provider about any current therapies is necessary to avoid potential interactions. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.